CG Oncology, Inc. — 8-K Filings
24 8-K filings on record
This page lists all 8-K filings submitted to the SEC by CG Oncology, Inc. (CGON), sorted by most recent first. Each row links to the full filing on EdgarLookup. CG Oncology, Inc. has filed 24 8-K documents with the SEC since 2023. To view all SEC filings by CG Oncology, Inc., see the full filings list.
All
10-K
10-Q
144
3
4
4/A
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
S-1
S-1/A
S-1MEF
S-3ASR
S-8
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K | 0001193125-26-079452 | Feb 27, 2026 | — |
| 8-K | 8-K | 0001193125-26-011855 | Jan 13, 2026 | — |
| 8-K | 8-K | 0001193125-26-008329 | Jan 9, 2026 | — |
| 8-K | 8-K | 0001193125-25-298160 | Nov 26, 2025 | Nov 22, 2025 |
| 8-K | 8-K | 0001193125-25-283108 | Nov 14, 2025 | Nov 10, 2025 |
| 8-K | 8-K | 0001193125-25-281672 | Nov 14, 2025 | — |
| 8-K | 8-K | 0001991792-25-000007 | Sep 9, 2025 | — |
| 8-K | 8-K | 0001991792-25-000004 | Sep 5, 2025 | — |
| 8-K | 8-K | 0000950170-25-105487 | Aug 8, 2025 | — |
| 8-K | 8-K | 0000950170-25-095296 | Jul 11, 2025 | Jul 7, 2025 |
| 8-K | 8-K | 0000950170-25-083088 | Jun 6, 2025 | Jun 5, 2025 |
| 8-K | 8-K | 0000950170-25-069825 | May 13, 2025 | — |
| 8-K | 8-K | 0000950170-25-058956 | Apr 28, 2025 | Apr 26, 2025 |
| 8-K | 8-K | 0000950170-25-046335 | Mar 28, 2025 | — |
| 8-K | 8-K | 0000950170-25-043497 | Mar 24, 2025 | — |
| 8-K | 8-K | 0000950170-25-004168 | Jan 10, 2025 | Jan 9, 2025 |
| 8-K | 8-K | 0001193125-24-271116 | Dec 5, 2024 | — |
| 8-K | 8-K | 0000950170-24-124636 | Nov 12, 2024 | — |
| 8-K | 8-K | 0000950170-24-093237 | Aug 8, 2024 | — |
| 8-K | 8-K | 0000950170-24-064309 | May 24, 2024 | — |
| 8-K | 8-K | 0001193125-24-134805 | May 9, 2024 | — |
| 8-K | 8-K | 0001193125-24-130800 | May 3, 2024 | — |
| 8-K | 8-K | 0001193125-24-038506 | Feb 16, 2024 | Feb 15, 2024 |
| 8-K | 8-K | 0001193125-24-018715 | Jan 30, 2024 | Jan 29, 2024 |